The company is replacing Ahn with former Executive Vice President and Chief Operating Officer Mark Schwartz. Schwartz has more than 30 years of experience in the biotechnology and life science industry.
Galena Biopharma will probably also add him to the company’s board of directors. Before joining the company, he was president and CEO of Apthera Inc. and later at Calyx Therapeutics.
“I am grateful to the Board of Directors for this opportunity and am excited to lead our talented and dedicated team…” said Schwartz. “I am passionate about our prospects, and look forward to working for the benefit of patients, physicians, and shareholders.”
GALE stock is down more than 5%.